Research raises possibility of effective, quick and reliable new test for bladder cancer
(Medical Xpress)—Research carried out at the University of Dundee has raised hopes of developing a quicker and more reliable new method of detecting urinary bladder cancer at an earlier stage.
A team from the University's School of Medicine, led by Dr Ghulam Nabi, has found that a process known as Raman spectroscopy (RS) has shown substantive promise in diagnosing bladder cancer.
At present, the most reliable way to test for this type of cancer is to carry out a biopsy on tissue removed from the patient's bladder. Possible side-effects include bleeding, discomfort and infection, while patient's currently face a two-week wait for the result of the biopsy.
RS is a spectroscopic technique used to study systems such as human tissue. A laser in RS equipment can detect changes in the structure of the tissue by measuring interactions, something with significant potential for diagnosing cancer at an early stage.
They found a correlation of more than 90 per cent in the results, suggesting that RS has potential to be used to make less-invasive and quicker diagnoses. As conclusions can be drawn instantly following the procedure, it may be possible to reduce the anxiety for patients awaiting the result of their test.
Dr Nabi said that, while the research was still at an early stage, the early results showed great promise for developing a new test for bladder cancer in future.
"Obviously, the earlier we diagnose cancer, the better the prognosis is for the patient," he said. "There are some specific difficulties in making a reliable early diagnosis of bladder cancer, and very often it is not diagnosed until the cancer has manifested itself as a variety of symptoms.
"What we have been looking to do is develop and early and reliable diagnosis of urinary bladder cancer. Raman spectroscopy tells us about technical structure of tissue before morphological changes in structure happen as a result of the cancer developing.
"The time that passes between a patient having a biopsy and receiving their results is an extremely anxious one for patients and their families. We believe that RS can remove this anxiety by providing a quick diagnosis and our results so far show that it does indeed show potential as a reliable tool for diagnosis.
"What we need to do now is expand our study population and refine the process until it is as reliable as biopsy but without the negative side-effects."
RS is named after the Indian Nobel Laureate Sir C.V Raman, whose 1928 work on the changes in the wavelength of light paved the way for the development of the technique. It has been used in various applications in chemistry for decades, and it has long been believed to hold potential for non-intrusive diagnosis of cancer.
A previous effort into the use of RS to diagnose bladder cancer was made some years ago but the probe inserted into the bladders of patients was unable to distinguish between cancer and inflammation. Dr Nabi's team build a more powerful probe with increased specifications which appears to be more effective.
The study, which appears in the edition of Analytical & Biological Chemistry published today, examined 14 patients who presented with symptoms of bladder cancer. The diagnosis made using RS was consistent with the biopsy results in 13 cases. Analysis of the results took place at MIT and the Norwegian University of Science.
Having proved the concept, Dr Nabi says the team will concentrate on creating a new probe for use in a far more extensive study.
"The next stage is to make a telescopic probe which we can insert into the bladder and that will tell us whether or not the patient is suffering from cancer as soon as it touches the tissue.
"We will need to look at a much bigger study population to see whether these very promising results translate but we are encouraged by what we have seen so far. If we can devise a probe reliable enough to remove the need for a biopsy this would allow us to diagnose cancer at a much earlier stage. It would also reduce the cost of carrying out a biopsy and then treating cancer at an advanced stage.
"Most importantly, it can improve the outcome for patients, reduce the complications that can arise from a biopsy and dispense with the lengthy wait for their results."
The research was supported by NHS Tayside's Endowment Funds.
In another study involving Dr Nabi recently, he and colleagues from Cambridge University explored whether it was possible to improve another of the tests for bladder cancer.
Patients with the disease pass cancer cells in their urine, and it is likely that anyone presenting with the symptoms will have a sample examined under a microscope before possibly being referred for a biopsy.
The problem is that the results are not definitive, and a significant variation exists between the interpretations of individual pathologists. The Cambridge/Dundee team proved that diagnosis can be made much more reliable by staining cells with an antibody-stained to mini microchromosomal protein prior to the test.
The antibody then sticks to the cancer cells, making them more visible as markers when looked at under the microscope.
Provided by
University of Dundee
-
New diagnostic test for bladder cancer
Jun 25, 2010 |
not rated yet |
0
-
Gene test shows which bladder cancer patients may have cancer spread
Jan 20, 2011 |
not rated yet |
0
-
New imaging agent has an appetite for dangerous prostate tumors
Dec 08, 2011 |
not rated yet |
0
-
Some diabetes drugs may increase risk of bladder cancer
Jul 03, 2012 |
not rated yet |
0
-
Selenium may prevent high risk-bladder cancer
Dec 08, 2008 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
-
Marie Curie's leukemia
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
Older prostate cancer patients should think twice before undergoing treatment
Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by researchers in the UCLA ...
Cancer
10 hours ago |
not rated yet |
0
|
Two radiotherapy treatments show similar morbidity, cancer control after prostatectomy
Intensity-modulated radiation therapy has become the most commonly used type of radiation in prostate cancer, but research from the University of North Carolina suggests that the therapy may not be more effective than older, ...
Cancer
12 hours ago |
not rated yet |
0
The compound in the Mediterranean diet that makes cancer cells 'mortal'
New research suggests that a compound abundant in the Mediterranean diet takes away cancer cells' "superpower" to escape death. By altering a very specific step in gene regulation, this compound essentially re-educates cancer ...
Cancer
13 hours ago |
4.8 / 5 (12) |
2
|
CT radiation risk less than risk of examination indicator
(HealthDay)—For young adults needing either a chest or abdominopelvic computed tomography (CT), the short-term risk of death from underlying morbidity is greater than the long-term risk of radiation-induced ...
Cancer
14 hours ago |
not rated yet |
0
Team finds mechanism linking key inflammatory marker to cancer
In a new study described in the journal Oncogene, researchers reveal how a key player in cell growth, immunity and the inflammatory response can be transformed into a primary contributor to tumor growth.
Cancer
19 hours ago |
not rated yet |
0
|
Genetic predictors of postpartum depression uncovered
Johns Hopkins researchers say they have discovered specific chemical alterations in two genes that, when present during pregnancy, reliably predict whether a woman will develop postpartum depression.
Child maltreatment increases risk of adult obesity
Children who have suffered maltreatment are 36% more likely to be obese in adulthood compared to non-maltreated children, according to a new study by King's College London. The authors estimate that the prevention or effective ...
After a decade, global AIDS program looks ahead
(AP)—The decade-old law that transformed the battle against HIV and AIDS in developing countries is at a crossroads. The dream of future generations freed from the epidemic is running up against an era ...
New immune system discovered
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.
Early-life traffic-related air pollution exposure linked to hyperactivity
Early-life exposure to traffic-related air pollution was significantly associated with higher hyperactivity scores at age 7, according to new research from the University of Cincinnati (UC) and Cincinnati Children's Hospital ...
Do salamanders hold the solution to regeneration?
Salamanders' immune systems are key to their remarkable ability to regrow limbs, and could also underpin their ability to regenerate spinal cords, brain tissue and even parts of their hearts, scientists have ...